Spruce Biosciences, Inc <SPRB.O>: B. Riley initiates coverage with buy rating; target price $160
SPRB•Related News
Allison Transmission Holdings Inc <ALSN.N>: JP Morgan Raises Target Price to $145 From $140
ALSN•
Dollar climbs on renewed Middle East attacks, Hormuz closure
TLT•
Herc Holdings Inc <HRI.N>: JP Morgan Raises Target Price to $165 From $140
HRI•
Goldman Sachs on oil: eventual expansion of pipeline capacity bypassing Hormuz poses downside risk to long-dated price assumption of $76/bbl
XLE•
South China Sea joint statement says China's maritime claims have no basis
SPY•